ET healthcare

ET Healthcare was founded in 2012 in Silicon Valley，United States. Its administration, R&D, marketing, and sales teams are based in Shanghai, while the manufacturing facilities, certified by GMP, ISO 13485, and CE, are based in Suzhou. ET Healthcare develops, produces and sells immunoassay diagnosis instruments, reagents and management software for clinical laboratories all over the world, covering areas such as biomarkers of diverse diseases on cardiac vascular diseases, inflammation, hormone, kidney function, and gastric function. It has now obtained more than 50 patents from China, Europe, Japan, and the United States. Besides, ET Healthcare is a corporate member of IFCC (The International Federation of Clinical Chemistry and Laboratory Medicine) and a member of Committee on IFCC Clinical Applications of Cardiac Bio-Markers. In addition, ET Healthcare’s “TOP” (Test-On-a-Probe) has gained its well-deserved recognition as the cutting-edge technology in the field by the IFCC and AACC (American Association for Clinical Chemistry). Experts around the world have used its products to conduct diagnostic researches on various diseases, publishing articles in journals, including COVID-19 research article in Nature. With its global vision and sufficient resources, ET Healthcare is proud to provide its customers with reliable products, personalized services, and academic support.